Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening

Clarisse F de Vries1, Samantha J Colosimo1, Roger T Staff1

  • 1From the Aberdeen Centre for Health Data Science, Institute of Applied Health Sciences (C.F.d.V., M.B., L.A.A.), School of Medicine, Medical Science and Nutrition (S.J.C., R.T.S.), and Grampian Data Safe Haven (DaSH), Aberdeen Centre for Health Data Science, Institute of Applied Health Sciences (J.A.D.), University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen AB24 3FX, Scotland; National Health Service Grampian (NHSG), Aberdeen Royal Infirmary, Aberdeen, Scotland (S.J.C., R.T.S., G.L.); Kheiron Medical Technologies, London, England (J.Y., D.D.); and School of Medicine, University of St Andrews, St Andrews, Scotland (D.J.H.).

Summary

Artificial intelligence (AI) in breast screening mammography shows promise but requires validation. AI performance varied with different thresholds and software versions, necessitating careful site-specific evaluation before widespread adoption.

Related Concept Videos